Skip to main content
SpringerLink
Log in

Nosocomial Candidemia in a tertiary care hospital in Saudi Arabia

  • Published:
Mycopathologia Aims and scope Submit manuscript

Abstract

Demographic information, risk factors, therapy, and outcome for all patients who had candidemia at King Fahad teaching hospital Al-khobar, between January 1995 and January 2000 were retrospectively reviewed. Thirty-two candidemic patients were identified. Candida parapsilosis was the most frequently isolated species (44%), followed by Candida tropicalis (25%), Candida albicans (19%), Candida krusei (6%), Candida glabrat a (3%), and Candida guilliermondi (3%). Risk factors included recent broad-spectrum antibiotics use (100%), ICU residency (71%), central venous catheters (66%), recent surgery (56%), total parenteral nutrition (43%), and immunosuppressive therapy (31%). Fluconazole was used before the onset of candidemia in only two patients. The overall mortality rate was 44%. Eight (25%) episodes of candidemia were not diagnosed and treated before the patient's demise. In view of the high mortality rate associated with hematogenous candidiasis, and lack of sensitive and specific laboratory tests necessary for the premortem diagnosis of infection, empirical antifungal therapy is recommended for high-risk patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995; 20: 1526–1530

    PubMed  CAS  Google Scholar 

  2. Wingard, J.R. Importance of Candida species other than C. albicans as pathogens in oncology patient. Clin Infect Dis 1995; 20: 115–125.

    PubMed  CAS  Google Scholar 

  3. Pfaller MA. Epidemiology and control of nosocomial fungal infection. Clin Infect Dis 1994; 19(suppl 1): S8-13.

    PubMed  Google Scholar 

  4. Pfaller MA. Nosocomial Candidiasis: Emerging Species, Reservoirs, and Modes of Transmission. Clin Infect Dis 1996; 22(suppl 2): S89–94.

    PubMed  Google Scholar 

  5. Abi-Said D, Anaissie E, Uzun O, Pinzcowski H, Vartivarian S. The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122–1128.

    PubMed  CAS  Google Scholar 

  6. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulosis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11: 379–390.

    PubMed  CAS  Google Scholar 

  7. Girmenia C, Martino P, De Bernardis F et al. Rising incidence of Candida parapsilosis candidemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis 1996; 23: 506–514.

    PubMed  CAS  Google Scholar 

  8. Harvey RL, Myers JP. Nosocomial fungemia in a large community teaching hospital. Arch Intern Med 1987; 147: 2117–2120.

    Article  PubMed  CAS  Google Scholar 

  9. Bross J Talbot GH, Maislin G, Hurwitz S, Strom BL. Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. Am J Med 1989; 87: 614–620.

    Article  PubMed  CAS  Google Scholar 

  10. Wingard JR, Merz WG, Rinaldi MG, Johnson TR, Karp JE, Saral R. Increased in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N Engl J Med 1991; 325: 1247–1247.

    Article  Google Scholar 

  11. Rex JH, Rinaldi MG, Pfaller MA. Resistance of Candida species to fluconazole. Antimicrobial Agents Chemother 1995; 39: 1–8.

    CAS  Google Scholar 

  12. Goodman JL, Winston DJ, Greenfield RA, et al. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. N Engl J Med 1992; 326: 845–851.

    Article  PubMed  CAS  Google Scholar 

  13. Winston DJ, Chandrasekar PH, Lazarus HM, et al. Fluconazole prophylaxis of fungal infections in patients with acute leukemia: result of a randomized placebo-controlled, double-blind, multicenter trial. Ann Intern Med 1993; 118: 459–503.

    Google Scholar 

  14. Pizzo PA, Walsh TJ. Fungal infections in the pediatric cancer patients. Semin Oncol 1990; 17(suppl 6): 6–9.

    PubMed  CAS  Google Scholar 

  15. Sobel J, Vazquez J. Candidemia and systemic candidiasis. Semin Respir Infect 1990; 5: 123–137.

    PubMed  CAS  Google Scholar 

  16. Meunier F, Aoun M, Bitar N. Candidemia in immunocompromised patients. Clin Infect Dis 1992; 14(suppl 1): S120–125.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. King Fahad Hospital of the University Al-khobar, Saudi Arabia

    H. A. Bukharie

Authors
  1. H. A. Bukharie
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bukharie, H.A. Nosocomial Candidemia in a tertiary care hospital in Saudi Arabia. Mycopathologia 153, 195–198 (2002). https://doi.org/10.1023/A:1014945517790

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1014945517790

Search

Navigation